Overview

Preoperative Hypnosis Versus Premedication in Gynecological Surgery

Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
0
Participant gender:
Female
Summary
The aim of this study is to evaluate the efficacy of an hypnosis session, performed on the eve of a laparoscopic gynecological surgery, on the level of immediate preoperative anxiety measured by State-Trait Anxiety Index (STAI-Y) self-administered questionnaire compared to premedication by alprazolamĀ®.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Central Hospital, Nancy, France
Treatments:
Alprazolam
Criteria
Inclusion Criteria:

- Patient's age: over 18 years

- Patient care and follow-up at the regional maternity center of Nancy (CHRU of Nancy)

- Female patient for whom gynecological laparoscopic surgery is programmed and lasting
longer than 1 hour (ovarian cyst, laparoscopy infertility, laparoscopic
promontofixation, noncarcinogenic assisted laparoscopy hysterectomy, endometriosis,
diagnostic laparoscopy, pyosalpinx, hydrosalpinx)

- Patient with Physical status score (ASA) score between 1 and 3

- With standardized anesthesia protocol

- Patient affiliated to a Social Security

- Patient has received complete information about the organization of the research and
has signed her informed consent

Exclusion Criteria:

- Pretreatment by benzodiazepines

- Known hypersensitivity to AlprazolamĀ® (including undocumented)

- Prohibition conditions to AlprazolamĀ®: Severe respiratory insufficiency, Sleep apnea
syndrome, Myasthenia, Severe acute or chronic hepatic impairment

- Ongoing major depressive episode

- Chronic use (> 1 month) of benzodiazepines or morphine or analgesics of level 2

- Participation in a therapeutic trial 6 months before inclusion in this trial

- Patient referred to in Articles L. 1121-5 to L. 1121-8 and L1122-2 of the Public
Health Code